Study suggests FenuLife galactomannan increases satiety.
The single-blind, crossover study, performed at the University of Minnesota, tested the effect of 4 grams or 8 grams of FenuLife galactomannan vs. placebo in 18 obese subjects. Following dosage of FenuLife or placebo in a beverage alongside a standardized breakfast, every 30 minutes for 3.5 hours subjects rated their feelings of hunger, satiety, fullness and prospective food consumption using visual analog scales (VAS). Samples of blood for analysis of blood glucose and insulin response were also taken. Subjects were then given an unlimited lunch buffet and recorded food intake for the rest of the day.
A statistically significant increase (P<0.05) was shown in measurements of satiety and fullness, with reduced ratings of hunger and prospective food consumption at 8 grams. In addition, this dosage showed a trend (P<0.11) toward reduced caloric intake at lunch. The researchers concluded that an 8-gram dose may have short-term beneficial effects in obese subjects. For further information: www.frutarom.com
|Printer friendly Cite/link Email Feedback|
|Title Annotation:||Research Highlights|
|Article Type:||Brief article|
|Date:||Nov 1, 2009|
|Previous Article:||MegaNatural BP grape seed extract may help lower blood pressure.|
|Next Article:||Research confirms weight management benefits of Cacti-Nea.|